The effects of single and multiple resistance mechanisms on bacterial response to meropenem [PDF]
Dominika T Fuhs +9 more
openalex +1 more source
High-dose versus standard-dose intermittent meropenem in critically ill patients: An observational cohort study. [PDF]
Bergmann F +5 more
europepmc +1 more source
Individualized therapy based on Meropenem serum levels - MIC data against non-Enterobacteriaceae resistance in ICU septic major burns [PDF]
Élson Mendes da Silva +16 more
openalex +1 more source
Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer [PDF]
G. Fleischhack
openalex +1 more source
Whole genome sequencing data analysis identified a cefotaxime-resistant <i>Empedobacter brevis</i> GBW-1 isolate from ground beef encoding a novel metallo-beta-lactamase variant, <i>blaEBR-6</i>. [PDF]
Jones D +5 more
europepmc +1 more source
Cross-resistance to meropenem, cephems, and quinolones in Pseudomonas aeruginosa
Nobuhisa Masuda, Satoshi Ohya
openalex +2 more sources
Evaluation of Ceftolozane-Tazobactam in Combination with Meropenem against Pseudomonas aeruginosa Sequence Type 175 in a Hollow-Fiber Infection Model [PDF]
M. Montero +9 more
openalex +1 more source
Time to Awaken a Forgotten Antibacterial Agent: A 10-year Nationwide Surveillance of Latamoxef Resistance in China Based on 46,716 Isolates and Establishment of Tentative Epidemiological Cut-Off Values. [PDF]
Chen P +9 more
europepmc +1 more source
A pbpB1 mutation causing reduced β-lactam susceptibility in clinical Listeria monocytogenes isolates. [PDF]
Wamp S +5 more
europepmc +1 more source

